GT
DXCM icon

Greenleaf Trust’s DexCom DXCM Stock Holding History

Greenleaf Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+2,996
New +$200K ﹤0.01% 838
2025
Q3 		– Sell
-12,944
Closed -$1.13M – 815
2025
Q2 		$1.13M Sell
12,944
-4,265
-25% -$334K 0.01% 295
2025
Q1 		$1.18M Buy
17,209
+3,114
+22% +$254K 0.01% 287
2024
Q4 		$1.1M Buy
14,095
+2,255
+19% +$167K 0.01% 300
2024
Q3 		$794K Sell
11,840
-2,671
-18% -$219K 0.01% 394
2024
Q2 		$1.65M Buy
14,511
+455
+3% +$57.5K 0.02% 205
2024
Q1 		$1.95M Buy
14,056
+7,645
+119% +$961K 0.02% 186
2023
Q4 		$796K Buy
6,411
+1,761
+38% +$180K 0.01% 332
2023
Q3 		$434K Sell
4,650
-568
-11% -$64K 0.01% 474
2023
Q2 		$671K Sell
5,218
-55
-1% -$6.65K 0.01% 377
2023
Q1 		$613K Sell
5,273
-196
-4% -$21.9K 0.01% 393
2022
Q4 		$619K Buy
5,469
+1,714
+46% +$188K 0.01% 384
2022
Q3 		$302K Buy
+3,755
New +$318K ﹤0.01% 534
2022
Q2 		– Sell
-3,720
Closed -$476K – 736
2022
Q1 		$476K Buy
3,720
+492
+15% +$53.8K 0.01% 435
2021
Q4 		$433K Buy
3,228
+212
+7% +$30.5K 0.01% 469
2021
Q3 		$412K Buy
3,016
+472
+19% +$59.5K 0.01% 462
2021
Q2 		$272K Sell
2,544
-28
-1% -$2.69K ﹤0.01% 612
2021
Q1 		$231K Buy
+2,572
New +$241K ﹤0.01% 645
2018
Q2 		– Sell
-668
Closed -$12K – 532
2018
Q1 		$12K Hold
668
– – ﹤0.01% 524
2017
Q4 		$10K Sell
668
-372
-36% -$4.83K ﹤0.01% 656
2017
Q3 		$13K Buy
+1,040
New +$18.4K ﹤0.01% 639

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Greenleaf Trust's DXCM Position: Q2 2026 in Review

Greenleaf Trust opened a new position in DexCom (DXCM) in Q2 2026: 2,996 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #838 among its holdings. This is a return to the name: Greenleaf Trust previously reported a position in DXCM as recently as Q2 2025.

Greenleaf Trust first reported a position in DXCM in Q3 2017 and has held it in 21 quarters since. The position peaked at $1.95M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Greenleaf Trust held 2,996 shares of DexCom worth $202K as of Q2 2026.
  • DexCom was a new Greenleaf Trust position in Q2 2026.
  • DexCom made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #838 holding.
  • Greenleaf Trust first reported a position in DexCom in Q3 2017 and has held it in 21 quarters since.
  • Greenleaf Trust's DexCom position peaked at $1.95M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.